Dr Reddys Laboratories (RDY) Profit After Tax (QoQ) (2009 - 2023)
Dr Reddys Laboratories (RDY) Profit After Tax (QoQ) (2009 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -1.16% |
| Mar 31, 2023 | 47.01% |
| Dec 31, 2022 | 76,973,584.21% |
| Jun 30, 2021 | 74.03% |
| Sep 30, 2020 | -175.00% |
| Jun 30, 2020 | 31.65% |
| Sep 30, 2019 | -55.56% |
| Jun 30, 2019 | 30.77% |
| Mar 31, 2019 | 85.71% |
| Dec 31, 2018 | -10.00% |
| Sep 30, 2018 | 6.06% |
| Jun 30, 2018 | 4.76% |
| Mar 31, 2018 | 43.18% |
| Dec 31, 2017 | -16.98% |
| Dec 31, 2016 | -74.42% |
| Mar 31, 2016 | 45.31% |
| Dec 31, 2015 | -26.44% |
| Sep 30, 2015 | -20.91% |
| Dec 31, 2014 | -21.43% |
| Mar 31, 2014 | -3.16% |